Apo Plus Station

Apo Plus Station, founded in 1993, operates as a specialized Contract Research Organization (CRO) and Contract Sales Organization (CSO) within the pharmaceutical and healthcare sectors. The firm provides critical support for drug development processes, offering comprehensive Clinical Research Associate (CRA) and Medical Representative (MR) services. By integrating clinical research expertise with strategic marketing support, Apo Plus Station enhances the operational efficiency and success rates of complex drug trials for its diverse client base. The company maintains a robust workforce of 500-1,000 employees dedicated to advancing medical research and commercialization strategies.

Headquartered in Nihonbashi, Tokyo, the organization leverages its deep industry knowledge to navigate the evolving regulatory landscape of the Japanese healthcare market. With a single primary location, the company focuses on delivering high-quality, specialized staffing and research solutions that address the specific needs of pharmaceutical manufacturers. Their service model is designed to bridge the gap between clinical development and market entry, ensuring that clients can effectively manage the lifecycle of their medical products from initial research phases through to commercial distribution.

Apo Plus Station continues to demonstrate significant market presence with annual revenues reaching $39.8M. The company remains committed to its core mission of supporting the pharmaceutical industry through professional service excellence and technical proficiency. Meet Apo Plus Station's team to learn more about their leadership and organizational structure, which drives their ongoing success in the competitive CRO and CSO landscape.